Polvoy, Ilona
Seo, Youngho
Parker, Matthew
Stewart, Megan
Siddiqua, Khadija
Manacsa, Harrison S.
Ravanfar, Vahid
Blecha, Joseph
Hope, Thomas A.
Vanbrocklin, Henry
Flavell, Robert R.
Barry, Jeffrey
Hansen, Erik
Villanueva-Meyer, Javier E.
Engel, Joanne
Rosenberg, Oren S.
Wilson, David M.
Ohliger, Michael A.
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (R01EB024014, R01EB025985, R01EB030897)
Article History
Received: 17 February 2022
Accepted: 30 May 2022
First Online: 23 June 2022
Declarations
:
: This study was approved by the Institutional Review Board of the University of California, San Francisco. Written informed consent was obtained from all subjects.
: Dr. Oren Rosenberg is currently employed by Janssen Biopharma in South San Francisco, 94080. Dr. Michael Ohliger reports travel award and speaking fee from General Electric, unrelated to the work presented in this manuscript. Dr. Thomas Hope reports consulting fees from ITM, Blue Earth Diagnostics, Ipsen; consulting fees and equity interest from RayzeBio and Curium; and research support from Clovis Oncology, Philips, and AAA/Novartis. All are unrelated to the work presented in this manuscript. All other authors have no relevant financial or non-financial interests to disclose.